KEY vs OVID · P/E 13, rev $7.51B vs rev $566.0K
KeyCorp (KEY) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported OVID revenue for 2024-12-31 was $566.0K. Net income was -$26.4M. Revenue was up 44.4% from 2023-12-31 to 2024-12-31. OVID currently screens at market cap $23.5M.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. OVID currently screens at market cap $23.5M.
Not investment advice. Open the KEY and OVID stock pages for the full models.
Not investment advice.